MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Core Insights - MacroGenics, Inc. is a biopharmaceutical company focused on developing innovative antibody-based therapeutics for cancer treatment [3] - Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 13, 2025 [1] - The company utilizes proprietary next-generation antibody-based technology platforms to generate its pipeline of product candidates [3] Company Overview - MacroGenics specializes in monoclonal antibody-based therapeutics for cancer [3] - The company has established several strategic collaborations with global pharmaceutical and biotechnology companies [3] - More information about MacroGenics can be found on its official website [3]